文献速递肝病

非酒精性脂肪性肝炎而非单纯性脂肪变性扰乱肝脏功能均一性:人体半乳糖正电子发射断层扫描研究

Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study.
PubMed 文献 · Aliment Pharmacol Ther · 2019-05-17

研究纳入25例经活检证实的非糖尿病NAFLD患者(13例NASH伴低级别纤维化、12例单纯性脂肪变性无纤维化)及9名健康对照,采用2-[18F]氟-2-脱氧-D-半乳糖PET和MRI质子密度脂肪分数评估肝脏代谢功能。NASH患者肝脏标准化摄取值为13.5(95%CI 12.1-14.9),低于单纯性脂肪变性和对照组(16.4(95%CI 15.6-17.1),P<0.001);NASH肝脏摄取变异系数为13.8%,高于单纯性脂肪变性11.6%和对照组10.2%(P=0.02)。结论认为NASH区域代谢肝功能更低且更不均匀,扰乱肝脏正常均一代谢功能。

要点

  • NASH患者肝脏2-[18F]氟-2-脱氧-D-半乳糖标准化摄取值为13.5(95%CI 12.1-14.9),低于单纯性脂肪变性和对照组(16.4(95%CI 15.6-17.1),P<0.001)。
  • 肝脏脂肪分数在NASH和单纯性脂肪变性中同等稀释标准化摄取,但NASH的纤维化和气球样变与摄取进一步降低相关。
  • NASH肝脏标准化摄取变异系数为13.8%,高于单纯性脂肪变性11.6%和对照组10.2%(P=0.02),反映功能异质性增加。

核心结论

  • NASH区域代谢肝功能低于单纯性脂肪变性和健康对照,且功能更不均匀,NASH扰乱肝脏正常均一代谢功能。

研究设计与样本

  • 研究纳入25例经活检证实的非糖尿病NAFLD患者(13例NASH伴低级别纤维化,12例单纯性脂肪变性无纤维化),另纳入9名健康人作为对照。
  • 受试者接受2-[18F]氟-2-脱氧-D-半乳糖正电子发射断层扫描及磁共振成像衍生的肝脏质子密度脂肪分数检测。

主要发现

  • NASH患者肝脏2-[18F]氟-2-脱氧-D-半乳糖标准化摄取值为13.5(95%CI 12.1-14.9),低于单纯性脂肪变性和对照组(16.4(95%CI 15.6-17.1),P<0.001)。
  • 肝脏脂肪分数在NASH和单纯性脂肪变性中同等稀释标准化摄取,但NASH的纤维化和气球样变与标准化摄取进一步降低相关。
  • NASH肝脏标准化摄取变异系数为13.8%,单纯性脂肪变性为11.6%,对照组为10.2%(P=0.02),反映NASH功能异质性增加。

关键数值与推荐

  • NASH患者标准化摄取13.5(95%CI 12.1-14.9) vs 单纯性脂肪变性和对照组16.4(95%CI 15.6-17.1),P<0.001。
  • 标准化摄取变异系数:NASH 13.8% vs 单纯性脂肪变性11.6% vs 对照组10.2%,P=0.02。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The disease severity of non-alcoholic fatty liver disease (NAFLD) and the distinction between simple steatosis and non-alcoholic steatohepatitis (NASH) are based on the pathohistological presence of steatosis, inflammation, ballooning and fibrosis. However, little is known about the relation between such structural changes and the function of the afflicted liver. AIMS: To investigate in vivo effects of hepatic fat fraction, ballooning and fibrosis on regional and whole liver metabolic function assessed by galactose elimination in NASH and simple steatosis. METHODS: Twenty-five biopsy-proven, nondiabetic patients with NAFLD (13 NASH with low-grade fibrosis, 12 simple steatosis with no fibrosis) underwent 2-[18 F]fluoro-2-deoxy-d-galactose positron emission tomography and magnetic resonance imaging-derived proton density fat fraction of the liver. Nine healthy persons were included as controls. RESULTS: In the NASH patients, the standardised hepatic uptake of 2-[18 F]fluoro-2-deoxy-d-galactose was reduced to 13.5 (95% confidence interval, 12.1-14.9) as compared with both simple steatosis and controls (16.4 (15.6-17.1), P < 0.001). Thus, the NASH patients had reduced regional metabolic liver function. The liver fat fraction diluted the standardised uptake equally in NASH and simple steatosis but the fibrosis and ballooning of NASH were associated with a further decrease. Moreover, the NASH livers exhibited increased variation in their standardised uptake values (coefficient of variation 13.8% vs 11.6% in simple steatosis and 10.2% in controls, P = 0.02), reflecting an increased functional heterogeneity. CONCLUSIONS: In NASH, the regional metabolic liver function was lower and more heterogeneous than in both simple steatosis and healthy controls. Thus, NASH disturbs the normal homogeneous metabolic function of the liver.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Eriksen PL, Thomsen KL, Larsen LP, et al. Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study. Aliment Pharmacol Ther. 2019. PMID: 31099410. doi:10.1111/apt.15293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。